Literature DB >> 18475618

Regulation of electrolyte transport with IL-1beta in rabbit distal colon.

F R Homaidan1, H Desai, L Zhao, G Broutman, R Burakoff.   

Abstract

Interletrkin-1beta levels are elevated in inflammatory bowel disease. In this study the mechanism by which interleukin-1beta affects electrolyte transport in the rabbit distal colon, was investigated. Interleukin-1beta caused a delayed increase in short-circuit current (I(sc)) which was attributed to protein synthesis since the effect was inhibited by cycloheximide. The interleukin-1beta induced increase in I(sc) was not affected by amiloride treatment but was completely inhibited by bumetanide or in chloride-free buffer and by indomethacin. Prostaglandin E(2) levels increased in tissue treated with interleukin-1beta, but this increase was reversed by cycloheximide. These data suggest that interleukin-1beta causes its effect via a yet to be identified second messenger, by increasing chloride secretion through a prostaglandin E(2) mediated mechanism.

Entities:  

Year:  1995        PMID: 18475618      PMCID: PMC2365610          DOI: 10.1155/S0962935195000111

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  33 in total

Review 1.  Interleukin-1 and beta-cell function: more than one second messenger?

Authors:  J M Argilés; J López-Soriano; M A Ortiz; J M Pou; F J López-Soriano
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

2.  Interleukin 1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation.

Authors:  J Saklatvala; F Guesdon
Journal:  J Rheumatol Suppl       Date:  1992-01

Review 3.  TNF and IL-1 in sepsis: good cytokines gone bad.

Authors:  T J Standiford; R M Strieter
Journal:  J Lab Clin Med       Date:  1992-08

4.  Interleukin 1 induces new protein formation in isolated rat islets of Langerhans.

Authors:  S Helqvist; B Sehested Hansen; J Johannesen; H Ullits Andersen; J Hoiriis Nielsen; J Nerup
Journal:  Acta Endocrinol (Copenh)       Date:  1989-07

5.  Interleukins 1 and 3 stimulate anion secretion in chicken intestine.

Authors:  E B Chang; M W Musch; L Mayer
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

6.  Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.

Authors:  J A Corbett; J L Wang; M A Sweetland; J R Lancaster; M L McDaniel
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells.

Authors:  K R Youngman; P L Simon; G A West; F Cominelli; D Rachmilewitz; J S Klein; C Fiocchi
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

8.  Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.

Authors:  J Pfeilschifter; C Schalkwijk; V A Briner; H van den Bosch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  IL-1 increases phospholipase A2 activity, expression of phospholipase A2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4.

Authors:  J S Bomalaski; M R Steiner; P L Simon; M A Clark
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

10.  Interleukin-1 up-regulates transcription of its own receptor in a human fibroblast cell line TIG-1: role of endogenous PGE2 and cAMP.

Authors:  T Takii; T Akahoshi; K Kato; H Hayashi; T Marunouchi; K Onozaki
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

View more
  1 in total

1.  Morphological and functional changes in the colonic epithelial cells in a rabbit model of colitis.

Authors:  F R Homaidan; L Zhao; T Palaia; V Donovan; R Burakoff
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.